2020 annual financial data
Royalty Pharma 2020 Operating margin
Direct answer
Operating margin was 75.17%.
Operating income was 1,595,399,000 USD and net income was 975,040,000 USD.
Operating cash flow was 2,034,629,000 USD.
Get free Royalty Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,122,353,000 USD
- Operating income
- 1,595,399,000 USD
- Net income
- 975,040,000 USD
- Operating cash flow
- 2,034,629,000 USD